First Trust Advisors LP Buys 13,422 Shares of Synopsys, Inc. $SNPS

First Trust Advisors LP lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 7.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 204,310 shares of the semiconductor company’s stock after purchasing an additional 13,422 shares during the period. First Trust Advisors LP owned approximately 0.11% of Synopsys worth $100,805,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in SNPS. Stanley Laman Group Ltd. grew its stake in shares of Synopsys by 542.9% during the third quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock worth $6,353,000 after purchasing an additional 10,874 shares during the period. Symphony Financial Ltd. Co. raised its position in shares of Synopsys by 4,780.9% in the 2nd quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after acquiring an additional 39,395 shares during the period. Empirical Asset Management LLC bought a new position in Synopsys during the 3rd quarter worth approximately $773,000. Strategic Advisors LLC raised its stake in Synopsys by 76.3% during the 3rd quarter. Strategic Advisors LLC now owns 7,578 shares of the semiconductor company’s stock worth $3,739,000 after buying an additional 3,279 shares during the period. Finally, Napean Trading & Investment Co Singapore PTE Ltd raised its stake in Synopsys by 17.6% during the 2nd quarter. Napean Trading & Investment Co Singapore PTE Ltd now owns 23,683 shares of the semiconductor company’s stock worth $12,142,000 after buying an additional 3,544 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Stock Down 1.1%

Shares of NASDAQ:SNPS opened at $437.41 on Monday. The firm has a market cap of $83.79 billion, a P/E ratio of 67.92, a P/E/G ratio of 3.56 and a beta of 1.15. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The business has a fifty day simple moving average of $466.71 and a 200 day simple moving average of $468.77. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, beating analysts’ consensus estimates of $3.56 by $0.21. The firm had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.39 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The business’s revenue was up 65.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.03 EPS. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Insider Activity at Synopsys

In other news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares in the company, valued at $6,338,270. The trade was a 2.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 4,157 shares of company stock valued at $1,945,036. Insiders own 0.56% of the company’s stock.

Wall Street Analyst Weigh In

SNPS has been the topic of a number of research reports. Morgan Stanley reaffirmed an “equal weight” rating and issued a $480.00 price target (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. KeyCorp increased their price objective on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. HSBC downgraded shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price for the company. in a research note on Friday, February 20th. JPMorgan Chase & Co. increased their price target on shares of Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Finally, Needham & Company LLC reiterated a “buy” rating on shares of Synopsys in a research report on Thursday, February 26th. Eight research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $531.00.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.